These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 11366696)
21. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule. Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337 [TBL] [Abstract][Full Text] [Related]
22. Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots. Maritz J; Preiser W; van Zyl GU J Clin Virol; 2012 Feb; 53(2):106-9. PubMed ID: 22196872 [TBL] [Abstract][Full Text] [Related]
23. Viral load is hot, but where are the guidelines? AIDS Alert; 1996 Jun; 11(6):64-5. PubMed ID: 11363542 [TBL] [Abstract][Full Text] [Related]
24. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes. Salimnia H; Moore EC; Crane LR; Macarthur RD; Fairfax MR J Clin Microbiol; 2005 Sep; 43(9):4635-9. PubMed ID: 16145119 [TBL] [Abstract][Full Text] [Related]
25. FDA review of viral load test kits. Food and Drug Administration. BETA; 1996 Mar; ():13. PubMed ID: 11363311 [TBL] [Abstract][Full Text] [Related]
26. Biological qualification of blood units: considerations about the effects of sample's handling and storage on stability of nucleic acids. Gessoni G; Barin P; Valverde S; Giacomini A; Di Natale C; Orlandini E; Arreghini N; De Fusco G; Frigato A; Fezzi M; Antico F; Marchiori G Transfus Apher Sci; 2004 Jun; 30(3):197-203. PubMed ID: 15172624 [TBL] [Abstract][Full Text] [Related]
27. Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay. Andreotti M; Pirillo M; Guidotti G; Ceffa S; Paturzo G; Germano P; Luhanga R; Chimwaza D; Mancini MG; Marazzi MC; Vella S; Palombi L; Giuliano M J Clin Virol; 2010 Jan; 47(1):4-7. PubMed ID: 19962936 [TBL] [Abstract][Full Text] [Related]
28. A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter. Piwowar-Manning EM; Henderson TA; Brisbin L; Jackson JB Am J Clin Pathol; 2003 Aug; 120(2):268-70. PubMed ID: 12931558 [TBL] [Abstract][Full Text] [Related]
29. Improved HIV viral load test approved by the FDA. Expert Rev Mol Diagn; 2002 Sep; 2(5):401. PubMed ID: 12271810 [No Abstract] [Full Text] [Related]
30. HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina. Hodara V; Monticelli A; Pampuro S; Salomón H; Jauregui Rueda H; Libonatti O Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):107-13. PubMed ID: 9695883 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Roche Amplicor Ultrasensitive and Abbott RealTime assays for samples with low or undetectable HIV RNA levels. Stephan CJ; Hill A; van Delft Y; Moecklinghoff C AIDS; 2012 Jul; 26(12):1580-1. PubMed ID: 22810373 [No Abstract] [Full Text] [Related]
32. Increased frequency of viral loads above 100,000 HIV-1 RNA copies/ml measured by Roche Cobas TaqMan assay in comparison with Cobas Amplicor assay. Grgic I; Zidovec Lepej S; Vince A; Begovac J J Clin Virol; 2010 May; 48(1):75-6. PubMed ID: 20226729 [No Abstract] [Full Text] [Related]
33. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system. Alp A; Hascelik G Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859 [TBL] [Abstract][Full Text] [Related]
34. New ultrasensitive test may cause ultra-confusion. AIDS Alert; 1997 Oct; 12(10):111-3. PubMed ID: 11364715 [TBL] [Abstract][Full Text] [Related]
35. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. Mine M; Bedi K; Maruta T; Madziva D; Tau M; Zana T; Gaolathe T; Moyo S; Seipone K; Ndwapi N; Essex M; Marlink R J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851 [TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. Damond F; Roquebert B; Bénard A; Collin G; Miceli M; Yéni P; Brun-Vezinet F; Descamps D J Clin Microbiol; 2007 Oct; 45(10):3436-8. PubMed ID: 17715371 [TBL] [Abstract][Full Text] [Related]
37. Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load. Perrin L; Pawlotsky JM; Bouvier-Alias M; Sarrazin C; Zeuzem S; Colucci G J Clin Microbiol; 2006 Dec; 44(12):4371-5. PubMed ID: 17005750 [TBL] [Abstract][Full Text] [Related]
38. FDA approves new HIV blood test from Roche. AIDS Read; 2009 Mar; 19(3):123. PubMed ID: 19338065 [No Abstract] [Full Text] [Related]
39. A new affordable flow cytometry based method to measure HIV-1 viral load. Greve B; Weidner J; Cassens U; Odaibo G; Olaleye D; Sibrowski W; Reichelt D; Nasdala I; Göhde W Cytometry A; 2009 Mar; 75(3):199-206. PubMed ID: 19034933 [TBL] [Abstract][Full Text] [Related]
40. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals. Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]